Zhi Yang

Dr. Zhi Yang

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Cell Host & Microbe
Verified
Journal Article
Open access
HWHaoqing Wang
Haoqing Wang
CBChristopher O. Barnes
Christopher O. Barnes
Zhi YangZhi Yang
Zhi Yang
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman
HIV-1 Env, a trimer of gp120-gp41 heterodimers, mediates membrane fusion after binding host receptor CD4. Receptor binding displaces V1V2 loops from Env's apex, allowing coreceptor binding and opening Env to enable gp41-mediated fusion. We present 3.54 Å and 4.06 Å cryoelectron microscopy structures of partially open soluble native-like Env trimers (SOSIPs) bound to CD4. One structure, a complex with a coreceptor-mimicking antibody that binds both CD4 and gp120, stabilizes the displaced V1V2 and reveals its structure. Comparing partially and fully open Envs with closed Envs shows that gp41 rearrangements are independent of the CD4-induced rearrangements that result in V1V2 displacement and formation of a 4-stranded bridging sheet. These findings suggest ordered conformational changes before coreceptor binding: (1) gp120 opening inducing side-chain rearrangements and a compact gp41 central helix conformation, and (2) 4-stranded bridging-sheet formation and V1V2 displacement. These analyses illuminate potential receptor-induced Env changes and inform design of therapeutics disrupting viral entry.

4 March 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAlexander A. Cohen
Alexander A. Cohen
Zhi YangZhi Yang
Zhi Yang
PGPriyanthi N. P. Gnanapragasam
Priyanthi N. P. Gnanapragasam
SOSusan Ou
Susan Ou
KDKim-Marie A. Dam
Kim-Marie A. Dam
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman
Current influenza vaccines do not elicit broadly protective immune responses against multiple strains. New strategies to focus the humoral immune response to conserved regions on influenza antigens are therefore required for recognition by broadly neutralizing antibodies. It has been suggested that B-cells with receptors that recognize conserved epitopes would be preferentially stimulated through avidity effects by mosaic particles presenting multiple forms of a variable antigen. We adapted SpyCatcher-based platforms, AP205 virus-like particles (VLPs) and mi3 nanoparticles (NPs), to covalently co-display SpyTagged hemagglutinin (HA) trimers from group 1 and group 2 influenza A strains. Here we show successful homotypic and heterotypic conjugation of up to 8 different HA trimers to both VLPs and NPs. We characterized the HA-VLPs and HA-NPs by cryo-electron tomography to derive the average number of conjugated HAs and their separation distances on particles, and compared immunizations of mosaic and homotypic particles in wild-type mice. Both types of HA particles elicited strong antibody responses, but the mosaic particles did not consistently elicit broader immune responses than mixtures of homotypic particles. We conclude that covalent attachment of HAs from currently-circulating influenza strains represents a viable alternative to current annual influenza vaccine strategies, but in the absence of further modifications, is unlikely to represent a method for making a universal influenza vaccine.

9 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
AWAnthony P. West
Anthony P. West
JWJoel O. Wertheim
Joel O. Wertheim
JWJade C. Wang
Jade C. Wang
TVTetyana I. Vasylyeva
Tetyana I. Vasylyeva
JHJennifer L. Havens
Jennifer L. Havens
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman
Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database (VDB), for quickly examining the changing landscape of spike mutations. Using VDB, we detect an emerging lineage of SARS-CoV-2 in the New York region that shares mutations with previously reported variants. The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701V. This lineage was first sequenced in late November 2020. Phylodynamic inference confirmed the rapid growth of the B.1.526 lineage. In concert with other variants, like B.1.1.7, the rise of B.1.526 appears to have extended the duration of the second wave of COVID-19 cases in NYC in early 2021. Pseudovirus neutralization experiments demonstrated that B.1.526 spike mutations adversely affect the neutralization titer of convalescent and vaccinee plasma, supporting the public health relevance of this lineage.

22 July 2020 in eLife
Verified
Journal Article
Open access
MLMark S Ladinsky
Mark S Ladinsky
PGPriyanthi Np Gnanapragasam
Priyanthi Np Gnanapragasam
Zhi YangZhi Yang
Zhi Yang
AWAnthony P West
Anthony P West
MKMichael S Kay
Michael S Kay
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman
Fusion of HIV-1 with the membrane of its target cell, an obligate first step in virus infectivity, is mediated by binding of the viral envelope (Env) spike protein to its receptors, CD4 and CCR5/CXCR4, on the cell surface. The process of viral fusion appears to be fast compared with viral egress and has not been visualized by EM. To capture fusion events, the process must be curtailed by trapping Env-receptor binding at an intermediate stage. We have used fusion inhibitors to trap HIV-1 virions attached to target cells by Envs in an extended pre-hairpin intermediate state. Electron tomography revealed HIV-1 virions bound to TZM-bl cells by 2–4 narrow spokes, with slightly more spokes present when evaluated with mutant virions that lacked the Env cytoplasmic tail. These results represent the first direct visualization of the hypothesized pre-hairpin intermediate of HIV-1 Env and improve our understanding of Env-mediated HIV-1 fusion and infection of host cells.

2 December 2019 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
Zhi YangZhi Yang
Zhi Yang
HWHaoqing Wang
Haoqing Wang
ALAlbert Z. Liu
Albert Z. Liu
HGHarry B. Gristick
Harry B. Gristick
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman

24 November 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
AEAmelia Escolano
Amelia Escolano
HGHarry B. Gristick
Harry B. Gristick
RGRajeev Gautam
Rajeev Gautam
ADAndrew T. DeLaitsch
Andrew T. DeLaitsch
MAMorgan Elizabeth Abernathy
Morgan Elizabeth Abernathy
Pamela J BjorkmanPamela J Bjorkman
Pamela J Bjorkman
Sequential immunization elicits antibodies against the V3-glycan patch of HIV-1 Env in rhesus macaques and also induces off-target antibody responses.